Osaic Holdings’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-13,763
| Closed | -$432K | – | 8092 |
|
|
2026
Q2 | $432K | Sell |
13,763
-3,125
| -19% | -$92.2K | ﹤0.01% | 3780 |
|
|
2026
Q1 | $418K | Sell |
16,888
-646
| -4% | -$15.4K | ﹤0.01% | 3526 |
|
|
2025
Q4 | $409K | Sell |
17,534
-8,346
| -32% | -$186K | ﹤0.01% | 3516 |
|
|
2025
Q3 | $527K | Sell |
25,880
-18,393
| -42% | -$378K | ﹤0.01% | 3385 |
|
|
2025
Q2 | $1.01M | Buy |
44,273
+33,314
| +304% | +$786K | ﹤0.01% | 2503 |
|
|
2025
Q1 | $266K | Sell |
10,959
-3,711
| -25% | -$83.6K | ﹤0.01% | 3410 |
|
|
2024
Q4 | $306K | Sell |
14,670
-4,764
| -25% | -$102K | ﹤0.01% | 3214 |
|
|
2024
Q3 | $386K | Sell |
19,434
-3,901
| -17% | -$72.3K | ﹤0.01% | 3104 |
|
|
2024
Q2 | $361K | Sell |
23,335
-2,726
| -10% | -$42.4K | ﹤0.01% | 3045 |
|
|
2024
Q1 | $415K | Sell |
26,061
-28,318
| -52% | -$427K | ﹤0.01% | 3083 |
|
|
2023
Q4 | $914K | Sell |
54,379
-14,619
| -21% | -$200K | ﹤0.01% | 2603 |
|
|
2023
Q3 | $807K | Buy |
68,998
+33,086
| +92% | +$443K | ﹤0.01% | 2831 |
|
|
2023
Q2 | $483K | Sell |
35,912
-10,867
| -23% | -$156K | ﹤0.01% | 3181 |
|
|
2023
Q1 | $776K | Buy |
46,779
+15,737
| +51% | +$260K | ﹤0.01% | 2718 |
|
|
2022
Q4 | $577K | Buy |
31,042
+7,456
| +32% | +$115K | ﹤0.01% | 2895 |
|
|
2022
Q3 | $302K | Buy |
23,586
+21,882
| +1,284% | +$259K | ﹤0.01% | 3377 |
|
|
2022
Q2 | $12K | Buy |
1,704
+507
| +42% | +$3.72K | ﹤0.01% | 5950 |
|
|
2022
Q1 | $10K | Buy |
1,197
+29
| +2% | +$205 | ﹤0.01% | 6115 |
|
|
2021
Q4 | $8K | Sell |
1,168
-94
| -7% | -$618 | ﹤0.01% | 6392 |
|
|
2021
Q3 | $7K | Buy |
1,262
+152
| +14% | +$831 | ﹤0.01% | 6375 |
|
|
2021
Q2 | $6K | Buy |
1,110
+191
| +21% | +$986 | ﹤0.01% | 6285 |
|
|
2021
Q1 | $4K | Buy |
919
+719
| +360% | +$2.86K | ﹤0.01% | 6246 |
|
|
2020
Q4 | $1K | Sell |
200
-1,900
| -90% | -$6.38K | ﹤0.01% | 6188 |
|
|
2020
Q3 | $7K | Buy |
2,100
+1,400
| +200% | +$5.48K | ﹤0.01% | 5432 |
|
|
2020
Q2 | $3K | Sell |
700
-300
| -30% | -$1.35K | ﹤0.01% | 5643 |
|
|
2020
Q1 | $4K | Buy |
+1,000
| New | +$4.1K | ﹤0.01% | 5425 |
|
Other funds holding CPRX
Osaic Holdings's CPRX Position: Q3 2026 in Review
Osaic Holdings sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 13,763 shares — an estimated $432K sold.
Osaic Holdings first reported a position in CPRX in Q1 2020 and held it in 26 quarters. The position peaked at $1.01M in Q2 2025. 3 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.
- Osaic Holdings reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Osaic Holdings sold 13,763 Catalyst Pharmaceutical shares in Q3 2026, an estimated $432K.
- Osaic Holdings first reported a position in Catalyst Pharmaceutical in Q1 2020 and held it in 26 quarters.
- Osaic Holdings's Catalyst Pharmaceutical position peaked at $1.01M in Q2 2025.
- 3 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.